Yangwa:GroupIntro

From yangwa

๐Ÿงฌ Lab Introduction

The Lab of Synthetic Biopharmaceutics is dedicated to engineering DNA/RNA-based nanostructures and logic-gated therapeutic platforms for precision medicine. Our research spans synthetic biology, cancer immunotherapy, and molecular programming. We aim to build programmable systems that bridge molecular sensing and disease targeting.

๐Ÿ‘ฅ Team Members

     <img src="https://via.placeholder.com/120" style="border-radius: 50%; margin-bottom: 12px;" />
Dr. Yang Wang
Principal Investigator
     <img src="https://via.placeholder.com/120" style="border-radius: 50%; margin-bottom: 12px;" />
่ฐขๅนฟ่ƒฝ
PhD Student
     <img src="https://via.placeholder.com/120" style="border-radius: 50%; margin-bottom: 12px;" />
ๅพๅฎ‰็„ถ
PhD Student

๐Ÿ“š Selected Publications

  • Wang Y et al. Nanorobots for acid-triggered TME targeting. Nature Nanotechnology, 2024.
  • Wang Y et al. RNA circuits for T cell logic activation in PDAC. Nature Biotechnology, 2023.
  • Wang Y et al. DNA origami vaccine carriers crossing the BBB. Advanced Materials, 2023.

๐Ÿ“ž Contact

๐Ÿ“ West China School of Pharmacy, Sichuan University
๐Ÿ“ง yangwa@lab.edu
๐ŸŒ <a href="http://yangwalab.com" style="color: #007BFF;">yangwalab.com</a>